Average Co-Inventor Count = 9.58
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (9 from 4,945 patents)
2. Genmab A+s (5 from 107 patents)
3. Roche Palo Alto LLC (4 from 322 patents)
4. F. Hoffmann-la Roche Ag (168 patents)
18 patents:
1. 9187565 - Antibodies against CD38 for treatment of multiple myeloma
2. 9181344 - Use of effector-function-deficient antibodies for treatment of auto-immune diseases
3. 9102733 - Anti-OX40L antibodies
4. 9040050 - Combination treatment of CD38-expressing tumors
5. RE44389 - Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies
6. RE44359 - Nucleic acid molecules encoding anti-P-selectin antibodies
7. RE43568 - Anti-P-selectin antibodies
8. 7868141 - Anti-OX40L antibodies
9. 7850962 - Human monoclonal antibodies against CD20
10. 7829673 - Antibodies against CD38 for treatment of multiple myeloma
11. 7824684 - Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodies
12. 7807158 - Antibodies against IL-13 receptor alpha1 and uses thereof
13. 7754867 - Nucleic acid molecules encoding anti-P-selectin antibodies
14. 7579157 - Antibody selection method against IGF-IR
15. 7572897 - Antibodies against insulin-like growth factor I receptor and uses thereof